Slow Thyroid? It Could Be Connected to PMOS

When the condition was first described in the 1930s, what we now know as Polyendocrine Metabolic Ovarian Syndrome (PMOS) was viewed primarily as a reproductive disorder. Women were typically identified by symptoms such as irregular or absent periods, excess body hair, and enlarged ovaries containing multiple follicles.

As science progressed, however, it became increasingly clear that this definition was too narrow. The condition affects much more than the ovaries, involving a complex interplay between reproductive hormones, metabolic health and the endocrine system.

This broader understanding led to an important change in 2026: Polycystic Ovary Syndrome (PCOS)was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The new name better reflects a condition that affects approximately one in eight women worldwide and can influence reproductive, metabolic, cardiovascular, dermatological and psychological health.

And one area researchers have been particularly interested in is the relationship between PMOS and thyroid function.

What Is the Connection Between PMOS and Thyroid Dysfunction?

PMOS and thyroid disorders can sometimes occur together, particularly hypothyroidism and autoimmune thyroid conditions such as Hashimoto’s thyroiditis. However, having PMOS does not necessarily mean that you have a thyroid disorder, and thyroid dysfunction itself is not currently a diagnostic criterion for PMOS.

The connection is important for another reason: thyroid disorders can produce symptoms that overlap with PMOS, including menstrual irregularities, changes in weight and metabolic health.

This is why PMOS remains, to some extent, a diagnosis of exclusion. Before making a diagnosis, a doctor may need to rule out other endocrine conditions that can mimic some of its symptoms, including thyroid dysfunction, elevated prolactin, congenital adrenal hyperplasia and, when clinically indicated, Cushing’s syndrome.

Along with weight gain, fatigue and mental fogginess are other signs of PCOS.

What Tests Can Help Identify PMOS?

There isn't one single blood test that can diagnose PMOS.

In adults, diagnosis generally involves identifying at least two of three features: ovulatory dysfunction or irregular menstrual cycles, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound or elevated anti-Müllerian hormone (AMH). Other conditions that could explain the symptoms must first be excluded.

Depending on your symptoms and medical history, your doctor may also look at several hormonal and metabolic markers.

Testosterone

Testosterone circulates in the blood primarily attached to proteins such as sex hormone-binding globulin (SHBG) and albumin, while only a small amount circulates freely.

Both total and free testosterone can be useful when assessing biochemical hyperandrogenism, one of the characteristic features of PMOS. When testosterone results are normal but symptoms strongly suggest androgen excess, additional hormones such as DHEAS or androstenedione may sometimes be considered.

SHBG

Sex hormone-binding globulin (SHBG) is a protein produced mainly by the liver that binds to sex hormones, including testosterone and estrogen.

Lower SHBG levels can mean that a greater proportion of testosterone remains biologically available. Low SHBG is also frequently associated with insulin resistance and other metabolic factors, making it another useful piece of the overall hormonal picture.

LH and FSH

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) help regulate ovulation and ovarian function.

Some women with PMOS have relatively higher LH levels compared with FSH, but the LH-to-FSH ratio is not considered a reliable diagnostic test for PMOS and can vary considerably from one woman to another.

These hormones may still be useful as part of a broader hormonal evaluation, particularly when a doctor is trying to rule out other causes of irregular or absent periods.

AMH

Anti-Müllerian hormone (AMH) is produced by small developing follicles in the ovaries and is commonly used as a marker of ovarian reserve.

Women with PMOS often have higher AMH levels because they tend to have a greater number of small ovarian follicles. Current guidelines allow AMH to be used as an alternative to ultrasound for identifying polycystic ovarian morphology in adults.

However, AMH should not be used as a stand-alone test for PMOS, and higher AMH does not simply mean that a woman has more or "better" eggs.

Don't Forget Metabolic Health

The word metabolic in PMOS is there for a reason.

Insulin resistance is a common feature of the condition, and women with PMOS have an increased risk of impaired glucose tolerance and type 2 diabetes. Your doctor may therefore recommend assessing glucose regulation as well as cholesterol and other cardiovascular risk factors.

Interestingly, routine fasting insulin measurements are not currently recommended as a definitive way to diagnose insulin resistance in PMOS because available tests are not sufficiently accurate for routine clinical use.

PMOS and Thyroid Health

If you have symptoms of both PMOS and a slow thyroid, the important question isn't necessarily whether one is causing the other. Instead, your doctor needs to determine whether the conditions are occurring together—or whether a thyroid disorder is producing symptoms that resemble PMOS.

A thyroid evaluation may include TSH and, when appropriate, free T4 and thyroid antibodies, particularly when Hashimoto's thyroiditis is suspected.

Once the underlying hormonal and metabolic picture becomes clearer, treatment can be tailored to the individual rather than simply treating a collection of symptoms.

How Can PMOS Be Managed?

There is no single approach that works for everyone with PMOS. Management depends on your symptoms, metabolic health, menstrual cycle, fertility goals and individual risk factors.

Lifestyle remains one of the foundations of treatment. Regular movement—even something as simple as walking—along with adequate sleep, a balanced diet and stress-management practices can support metabolic and cardiovascular health.

Depending on the individual, doctors may also recommend treatments such as hormonal contraceptives, medications targeting androgen-related symptoms, fertility treatments or metformin, particularly when metabolic features are present.

Supplements such as inositol and vitamin D are also being studied in PMOS. Inositol may offer metabolic benefits for some women, although the evidence remains less certain than for established medical treatments. Vitamin D supplementation is most appropriate when levels are insufficient or deficient.

Iodine, on the other hand, deserves caution. While iodine is essential for normal thyroid hormone production, taking more than you need can disrupt thyroid function and, in susceptible individuals, may contribute to either hypothyroidism or hyperthyroidism—particularly when an underlying thyroid condition is present.

PMOS Is More Than Irregular Periods

Addressing PMOS isn't simply about fertility, weight or aesthetics.

The condition is associated with increased metabolic and cardiovascular risk factors, including insulin resistance, abnormal glucose regulation and type 2 diabetes. This is one reason the new name matters: it encourages us to look beyond the ovaries and consider the health of the whole body.

If you experience irregular periods, excess facial or body hair, persistent acne, hair thinning, difficulty conceiving or signs of metabolic dysfunction, speak with your doctor about whether further hormonal and metabolic testing may be appropriate.

Certain supplements and adaptogenic ingredients may also offer additional support for stress, metabolic health and hormone-related symptoms. Products such as Semaine can be considered as part of a broader wellness approach, depending on their ingredients and your individual needs.

The shift from PCOS to PMOS is more than a change in terminology. It reflects a growing understanding that this common condition involves an interconnected network of hormones, metabolism and reproductive health—and that recognizing the bigger picture may ultimately lead to better care.

Let us know how you feel!